Editorial

U2

Developmental neurotoxicity – Challenges in the 21st century and in vitro opportunities

129-156

Experiences of the REACH testing proposals system to reduce animal testing

107-128

Of rodents and men: Species-specific glucose regulation and type 2 diabetes research

157-176

Safety evaluations under the proposed US Safe Cosmetics and Personal Care Products Act of 2013: Animal use and cost estimates

177-208

Endpoint matrix: a conceptual tool to promote consideration of the multiple dimensions of humane endpoints

209-213

EU member state government contribution to alternative methods

215-218

German Animal Welfare Act in breach with Directive 2010/63/EU

219-222

Alternatives initiative in Sri Lanka: Pre- and post-conference workshops at the Inaugural Scientific Conference of the Sri Lanka Association for Laboratory Animal Science

224-226

International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes

223-224

Addendum to Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test

226

Corners

227-233

News

234-239

Calendar

214

Imprint

240

Cover